Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers

Recent advances in treating cutaneous melanoma have resulted in impressive patient survival gains. Refinement of disease staging and accurate patient risk classification have significantly improved our prognostic knowledge and ability to accurately stratify treatment. Undoubtedly, the most important...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiliopoulou, Pavlina, Vornicova, Olga, Genta, Sofia, Spreafico, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862040/
https://www.ncbi.nlm.nih.gov/pubmed/36674809
http://dx.doi.org/10.3390/ijms24021294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862040/
https://www.ncbi.nlm.nih.gov/pubmed/36674809
http://dx.doi.org/10.3390/ijms24021294

Ejemplares similares